Back

The impact of very highly elevated lipoprotein(a) levels on the early onset, complexity, and extent of coronary artery disease

31 August 2025 (15:15 - 16:00)
Organised by: Logo
Congress Presentation Part of: Lipid-lowering and inflammation Angiography, Invasive Imaging ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Mr Casper Coerkamp

Amsterdam (Netherlands (The))

7 More presentations in this session

Presentation thumbnail
Association of colchicine with cardiovascular outcomes in patients with acute coronary syndrome
Doctor M. Tao (Hartford, US)
Abstract Slides Video
Presentation thumbnail
Non-steroidal anti-inflammatory drug use after invasive and non-invasive diagnostic procedures for coronary artery disease by the degree of disease: a Danish drug utilization study (2008-2021)
Doctor A. Bech-Drewes (Aarhus, DK)
Abstract Slides Video
Presentation thumbnail
Healed plaque and systemic thrombogenicity in patients with chronic coronary syndrome
Doctor D. Kinoshita (Yamagata, JP)
Abstract Slides Video
Presentation thumbnail
Effects of vitamin k2 and d3 supplementation on cardiac and systemic inflammation: a randomized controlled trial
Doctor S. Hasific (Odense, DK)
Abstract Slides Video
Presentation thumbnail
Emerging role of inflammatory pathways on coronary atherosclerotic risk in patients with chronic coronary syndromes under current treatment
Doctor C. Caselli (Pisa, IT)
Abstract Slides Video

Access the full session

Session thumbnail
Lipid-lowering and inflammation

The Event

Event poster

ESC Congress 2025

31 August 2025 15:15 CET
You may be interested in
thumbnail
Congress Presentation
Lipoprotein(a) levels in acute myocardial infarction patients and their associations with prior events and coronary artery disease severity: a real-world cohort study
thumbnail
Congress Presentation
Comparison of lipoprotein (a) levels in patients with a history of coronary artery disease and in normal subjects
thumbnail
Congress Presentation
Influence of the non-lipoprotein(a) apolipoprotein B/lipoprotein(a) ratio and other risk factors on coronary arterial aterosclerotic burden in acute coronary syndrome.

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources